New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

bausch & lomb (nz) ltd - disodium edetate dihydrate 0.01%; thiomersal 0.004% - contact lens solution - 0.01%/0.004% - active: disodium edetate dihydrate 0.01% thiomersal 0.004%

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; poloxamer 1.3%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01/1.3/0.004%w/v - active: disodium edetate dihydrate 0.01%{relative} poloxamer 1.3%{relative} thiomersal 0.004%{relative}

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

morgan and hall ltd - disodium edetate dihydrate 0.01%{relative}; miranol 2mca 0.2%{relative}; thiomersal 0.004%{relative} - contact lens solution - 0.01%/0.2%/0.004% - active: disodium edetate dihydrate 0.01%{relative} miranol 2mca 0.2%{relative} thiomersal 0.004%{relative}

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - disodium edetate, quantity: 30 mg/ml - injection, concentrated - excipient ingredients: water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, cons

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - sodium ascorbate, quantity: 100 mg/ml; disodium edetate, quantity: 60 mg/ml - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide - 1. disodium edetate is particularly effective in treating lead accumulation and lead poisoning. this is especially so where there is a concomitant hypercalcaemic problem (refer "indications (2)"). however it must be noted that disodium edetate is equally effective with calcium disodium edetate in removing heavy metals, even in the absence of hypercalcaemia. for patients with elevated serum calcium or hypermobility of their body pools of calcium where there may be transiently or prolonged raised serum calcium (see "indications (2)"), the edta of choice for removing heavy metals may be disodium edetate. there are no recognised safe limits for lead intoxication. lead poisoning may occur by ingestion or inhalation of lead dust or fumes. poisoning is manifested by a metallic taste, anorexia, irritability, apathy, abdominal colic, vomiting, diarrhoea, constipation, headache, leg cramps, black stools, oliguria, stupor, convulsions, palsies and coma. chronic lead poisoning causes variable involvement of the central n

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; thiomersal 0.00115% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     thiomersal 0.00115%

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; sodium polymetaphosphate 0.2%;  ; thiomersal 0.001% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     sodium polymetaphosphate 0.2%   thiomersal 0.001%

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - disodium edetate dihydrate 0.2%{relative}; hyetellose 0.792%{relative}; sodium chloride 0.422%{relative} - contact lens solution - active: disodium edetate dihydrate 0.2%{relative} hyetellose 0.792%{relative} sodium chloride 0.422%{relative} excipient: dibasic sodium phosphate monobasic sodium phosphate dihydrate polyvinyl alcohol purified water thiomersal tyloxapol

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - disodium edetate dihydrate 0.1%{relative}; polysorbate 80 0.05%{relative}; polyvinyl alcohol 0.75%{relative}; sodium chloride 0.458%{relative} - contact lens solution - active: disodium edetate dihydrate 0.1%{relative} polysorbate 80 0.05%{relative} polyvinyl alcohol 0.75%{relative} sodium chloride 0.458%{relative} excipient: dibasic sodium phosphate hyetellose monobasic sodium phosphate dihydrate purified water thiomersal